Admission of Shares on AIM

22nd Nov 2007 08:00

Imperial Innovations Group plc22 November 2007 Imperial Innovations Group plc ("Imperial Innovations") 22 November 2007 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO ORFROM THE UNITED STATES, CANADA, AUSTRALIA, REPUBLIC OF IRELAND OR JAPAN OR ANYOTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANTLAWS OF SUCH JURISDICTION. This announcement does not constitute an offer orinvitation to purchase or subscribe for any securities. Imperial Innovations Group plc (the 'Company') Admission of shares on AIM Imperial Innovations Group plc today announces the admission of 8,108,108Ordinary Shares of 3 1/33 pence each ('Ordinary Shares') to the AIM Market ofLondon Stock Exchange plc ('AIM') and the commencement of unconditional dealingsin those shares ('Admission'). The Company has raised gross proceeds of £30 million through the issue of8,108,108 Ordinary Shares to institutional investors at a price of 370 pence perOrdinary Share (the 'Placing'). JPMorgan Cazenove Limited ('JPMorgan Cazenove') is nominated advisor and brokerto the Company. For more information contact: Imperial InnovationsMartin Knight, Chairman +44 (0)20 7594 1403Susan Searle, Chief Executive Officer +44 (0)20 7594 6591 M:CommunicationsPatrick d'Ancona / Eleanor Williamson +44 (0)20 7153 1539 JP Morgan Cazenove (NOMAD to Imperial Innovations)Steve Baldwin +44(0)20 7588 2828 Notes to Editors About Imperial InnovationsImperial Innovations is one of the UK's leading technology transfer andcommercialisation companies. The company was founded in 1986 and its ordinaryshares admitted to trading on the AIM Market of London Stock Exchange plc inJuly 2006, raising £25 million at an offer price of 365p and £1 million by meansof a public offer. The company's integrated approach encompasses the identification of ideas,protection of intellectual property, development and licensing of technology andformation, incubation and investment in technology businesses. A wide range oftechnologies are commercialised within the areas of healthcare, energy,environment and emerging technology trends. Based at Imperial College London, the company has established equity holdings in74 technology businesses and is managing 133 commercial agreements as of 31 July2007. Imperial Innovations also commercialises technologies originating fromoutside Imperial College through incubation contracts with the Carbon Trust andWRAP and has commercialisation contracts with a number of multinationalcorporations including BAE Systems. www.imperialinnovations.co.uk This information is provided by RNS The company news service from the London Stock Exchange

---

Related Shares:

Imperial Innovations Group